TRDA20250620C17.5
TRDA Jun 20 2025 17.50 Call (TRDA250620C00017500)
option OPRA

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.